User profiles for Gary Cook
![]() | Gary CookKing's College London Verified email at kcl.ac.uk Cited by 22527 |
The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping
Background Radiomic features may quantify characteristics present in medical imaging.
However, the lack of standardized definitions and validated reference values have hampered …
However, the lack of standardized definitions and validated reference values have hampered …
Imaging biomarker roadmap for cancer studies
…, LP Clarke, S Collette, GJ Cook… - Nature reviews Clinical …, 2017 - nature.com
Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs
used daily in oncology include clinical TNM stage, objective response and left ventricular …
used daily in oncology include clinical TNM stage, objective response and left ventricular …
Introduction to radiomics
…, P Szczypiński, P Gibbs, G Cook - Journal of Nuclear …, 2020 - jnm.snmjournals.org
Radiomics is a rapidly evolving field of research concerned with the extraction of quantitative
metrics—the so-called radiomic features—within medical images. Radiomic features …
metrics—the so-called radiomic features—within medical images. Radiomic features …
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
Background Tumor spatial heterogeneity is an important prognostic factor, which may be
reflected in medical images Methods Image texture analysis is an approach of quantifying …
reflected in medical images Methods Image texture analysis is an approach of quantifying …
Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
GJ Cook, S Houston, R Rubens, MN Maisey… - Journal of clinical …, 1998 - ascopubs.org
PURPOSE 99mTechnetium methylene diphosphonate (99mTc MDP) bone scintigraphy is
currently the method of choice for the detection of bone metastases, but 18F-fluoro-deoxy-D-…
currently the method of choice for the detection of bone metastases, but 18F-fluoro-deoxy-D-…
Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis
…, M Siddique, A Roy, PK Marsden, GJR Cook - European journal of …, 2013 - Springer
18 F-Fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG
PET/CT) is now routinely used in oncological imaging for diagnosis and staging and …
PET/CT) is now routinely used in oncological imaging for diagnosis and staging and …
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
Introduction Breast cancer remains a significant scientific, clinical and societal challenge.
This gap analysis has reviewed and critically assessed enduring issues and new challenges …
This gap analysis has reviewed and critically assessed enduring issues and new challenges …
[BOOK][B] Teaching percussion
G Cook - 1988 - miemagazine.com
Since the publication of the first edition in 1988, Teaching Percussion has been used
throughout the world. My goal with the revisions and updates to the second edition, published in …
throughout the world. My goal with the revisions and updates to the second edition, published in …
[BOOK][B] George Herbert Mead: The making of a social pragmatist
GA Cook - 1993 - books.google.com
This groundbreaking study details the intellectual development of George Herbert Mead as
a thinker of great originality and as a practitioner of social reform. Gary Cook traces the …
a thinker of great originality and as a practitioner of social reform. Gary Cook traces the …
Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation
GJR Cook, I Fogelman, MN Maisey - Seminars in nuclear medicine, 1996 - Elsevier
The use of positron-emission tomography in clinical practice is increasing, particularly with
the use of 18-fluoro-2-deoxyglucose (FDG) for oncological studies. As in other imaging …
the use of 18-fluoro-2-deoxyglucose (FDG) for oncological studies. As in other imaging …